Apellis Provides Update on Ongoing Regulatory Review of Pegcetacoplan for GA in the European Union
Conference call today at 8:30 a.m. ETWALTHAM, Mass., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced...
Read more